ncRNA name
CircTNPO3
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-1299/NEK2
Cancer name
Ovarian Cancer
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
20(<55)+28(>=55)
Age range and number
Not available
PMID
Description
Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299/NEK2 Signaling Pathway
Tissue resource
paired resected ovarian cancer tissues and adjacent normal tissues
human ovarian carcinoma cell lines SKOV3
human ovarian carcinoma cell lines HeyA-8
normal ovarian epithelial cell lines IOSE-80
Experiment
48
Institute
Affiliated Tumor Hospital of Xiang-Ya School of Medicine
American Type Culture Collection
Country
China
United States
Continent
Asia
North Amercian